Chief of Thoracic Oncology and Co-director
Druckenmiller Center for Lung Cancer Research
Dr Rudin is the Chief of Thoracic Oncology, co-director of the Druckenmiller Center for Lung Cancer Research and holds the Sylvia Hassenfield Chair in Lung Cancer Research at Memorial Sloan Kettering Cancer Center. Dr Rudin conducts a broad programme of both clinical and laboratory research, including novel targeting approaches for both small cell and non-small cell lung cancers. He has been a member of multiple graduate training programmes and has served as mentor for many successful PhD students and post-doctoral researchers.
The Rudin laboratory was among the first to conduct comprehensive analyses of the small cell lung cancer genome and epigenome. The Rudin laboratory was also among the first to establish, expand, and characterize lung cancer patient derived xenograft models, and now houses one of the largest libraries of such models. These have been used extensively as a preclinical platform for testing novel therapeutic approaches by the Rudin laboratory and others. In parallel, Dr Rudin has directed clinical research in lung cancer throughout his career, at the University of Chicago, Johns Hopkins and Sloan Kettering, from first-in human phase I trials to leadership of national cooperative group studies. Recent awards include the Bonnie J. Addario Asclepos Award and the National Cancer Institute Director’s Service Award.